S&P 500   3,616.69 (-0.60%)
DOW   29,579.62 (-1.11%)
QQQ   299.06 (+0.02%)
AAPL   120.46 (+3.32%)
MSFT   212.81 (-1.12%)
FB   275.27 (-0.91%)
GOOGL   1,754.81 (-1.80%)
AMZN   3,161.17 (-1.07%)
TSLA   578.64 (-1.22%)
NVDA   531.75 (+0.25%)
BABA   264.09 (-4.48%)
CGC   28.88 (-0.41%)
GE   10.25 (-1.44%)
MU   64.21 (-0.03%)
AMD   92.10 (+5.63%)
T   28.75 (-0.96%)
NIO   51.43 (-4.76%)
F   9.11 (+0.22%)
ACB   11.69 (+11.65%)
NFLX   488.78 (-0.53%)
BA   211.71 (-2.21%)
GILD   59.99 (-0.07%)
DIS   147.30 (+0.12%)
S&P 500   3,616.69 (-0.60%)
DOW   29,579.62 (-1.11%)
QQQ   299.06 (+0.02%)
AAPL   120.46 (+3.32%)
MSFT   212.81 (-1.12%)
FB   275.27 (-0.91%)
GOOGL   1,754.81 (-1.80%)
AMZN   3,161.17 (-1.07%)
TSLA   578.64 (-1.22%)
NVDA   531.75 (+0.25%)
BABA   264.09 (-4.48%)
CGC   28.88 (-0.41%)
GE   10.25 (-1.44%)
MU   64.21 (-0.03%)
AMD   92.10 (+5.63%)
T   28.75 (-0.96%)
NIO   51.43 (-4.76%)
F   9.11 (+0.22%)
ACB   11.69 (+11.65%)
NFLX   488.78 (-0.53%)
BA   211.71 (-2.21%)
GILD   59.99 (-0.07%)
DIS   147.30 (+0.12%)
S&P 500   3,616.69 (-0.60%)
DOW   29,579.62 (-1.11%)
QQQ   299.06 (+0.02%)
AAPL   120.46 (+3.32%)
MSFT   212.81 (-1.12%)
FB   275.27 (-0.91%)
GOOGL   1,754.81 (-1.80%)
AMZN   3,161.17 (-1.07%)
TSLA   578.64 (-1.22%)
NVDA   531.75 (+0.25%)
BABA   264.09 (-4.48%)
CGC   28.88 (-0.41%)
GE   10.25 (-1.44%)
MU   64.21 (-0.03%)
AMD   92.10 (+5.63%)
T   28.75 (-0.96%)
NIO   51.43 (-4.76%)
F   9.11 (+0.22%)
ACB   11.69 (+11.65%)
NFLX   488.78 (-0.53%)
BA   211.71 (-2.21%)
GILD   59.99 (-0.07%)
DIS   147.30 (+0.12%)
S&P 500   3,616.69 (-0.60%)
DOW   29,579.62 (-1.11%)
QQQ   299.06 (+0.02%)
AAPL   120.46 (+3.32%)
MSFT   212.81 (-1.12%)
FB   275.27 (-0.91%)
GOOGL   1,754.81 (-1.80%)
AMZN   3,161.17 (-1.07%)
TSLA   578.64 (-1.22%)
NVDA   531.75 (+0.25%)
BABA   264.09 (-4.48%)
CGC   28.88 (-0.41%)
GE   10.25 (-1.44%)
MU   64.21 (-0.03%)
AMD   92.10 (+5.63%)
T   28.75 (-0.96%)
NIO   51.43 (-4.76%)
F   9.11 (+0.22%)
ACB   11.69 (+11.65%)
NFLX   488.78 (-0.53%)
BA   211.71 (-2.21%)
GILD   59.99 (-0.07%)
DIS   147.30 (+0.12%)
Log in
OTCMKTS:TRUMY

Terumo Stock Forecast, Price & News

$39.95
-0.41 (-1.02 %)
(As of 11/27/2020 09:59 PM ET)
Add
Compare
Today's Range
$39.67
Now: $39.95
$40.55
50-Day Range
$36.76
MA: $39.35
$43.10
52-Week Range
$25.80
Now: $39.95
$44.27
Volume11,900 shs
Average Volume19,083 shs
Market Capitalization$30.34 billion
P/E Ratio38.79
Dividend Yield0.23%
Beta0.29
Terumo Corporation develops, manufactures, and distributes medical devices and services worldwide. The company operates through three segments: Cardiac and Vascular Company, General Hospital Company, and Blood and Cell Technologies Company. The Cardiac and Vascular Company segment offers angiographic guidewires, angiographic catheters, introducer sheaths, vascular closure devices, PTCA balloon catheters, coronary stents, self-expanding peripheral stent, intravascular ultrasound systems, drug-eluting stents, imaging catheters, and others; coils and stents for treating cerebral aneurysm, aspiration catheters and clot retrievers for treating ischemic stroke, and others; oxygenators, flow diverters, cardio-pulmonary bypass systems, and others; and artificial vascular and stent grafts. The General Hospital Company segment provides infusion pumps, syringe pumps, solution sets, syringes, I.V. solutions, pain management products, nutritious food, adhesion barriers, blood glucose monitoring systems, blood pressure monitors, digital thermometers, and others; and contract manufacturing of prefilled syringes, devices to pharmaceutical companies for use in drug kits, such as prefillable syringes, needles for pharmaceutical packaging business, and others. The Blood and Cell Technologies Company segment offers blood bags, automated blood collection systems, automated blood component processing systems, pathogen reduction technology, automated centrifugal apheresis systems, cell expansion system, and others. The company was formerly known as Sekisen Ken-onki Corporation and changed its name to Terumo Corporation in October 1974. Terumo Corporation was founded in 1921 and is headquartered in Tokyo, Japan.
Read More

Beat the Market (BTM) Rank

Analyst Opinion: 0.0Community Rank: 2.4Dividend Strength: 1.7Insider Behavior: 0.0Valuation: 1.9 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.19 out of 5 stars


Industry, Sector and Symbol

Industry Medical & hospital equipment
Sub-IndustryN/A
SectorMedical
Current SymbolOTCMKTS:TRUMY
Previous SymbolNASDAQ:TRUMY
CUSIPN/A
CIKN/A
Phone813-3374-8111
Employees26,438

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$5.79 billion
Cash Flow$1.75 per share
Book Value$9.14 per share

Profitability

Net Income$783.93 million

Miscellaneous

Market Cap$30.34 billion
Next Earnings Date12/3/2020 (Estimated)
OptionableNot Optionable
$39.95
-0.41 (-1.02 %)
(As of 11/27/2020 09:59 PM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive TRUMY News and Ratings via Email

Sign-up to receive the latest news and ratings for TRUMY and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Terumo (OTCMKTS:TRUMY) Frequently Asked Questions

How has Terumo's stock been impacted by Coronavirus (COVID-19)?

Terumo's stock was trading at $32.71 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Since then, TRUMY shares have increased by 22.1% and is now trading at $39.95.
View which stocks have been most impacted by COVID-19
.

Do Wall Street analysts recommend investors buy shares of Terumo?

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Terumo in the last year. There are currently 1 hold rating for the stock, resulting in a consensus recommendation of "Hold."
View analyst ratings for Terumo
or view MarketBeat's top 5 stock picks.

What stocks does MarketBeat like better than Terumo?

Wall Street analysts have given Terumo a "Hold" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's winning trading ideas this year have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Terumo wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

When is Terumo's next earnings date?

Terumo is scheduled to release its next quarterly earnings announcement on Thursday, December 3rd 2020.
View our earnings forecast for Terumo
.

Are investors shorting Terumo?

Terumo saw a drop in short interest during the month of October. As of October 30th, there was short interest totaling 11,700 shares, a drop of 32.8% from the October 15th total of 17,400 shares. Based on an average daily trading volume, of 28,100 shares, the days-to-cover ratio is currently 0.4 days.
View Terumo's Short Interest
.

Who are some of Terumo's key competitors?

Who are Terumo's key executives?

Terumo's management team includes the following people:
  • Mr. Shinjiro Sato, Pres, CEO & Director
  • Mr. Naoki Muto, Chief Accounting & Financial Officer and Exec. Officer
  • Mr. Hiroaki Kasukawa, CTO & Exec. Officer
  • Mr. Katsuya Takeuchi, Exec. Officer, Chief Information Officer & GM of IT Dept.
  • Kenichi Hata, Gen. Mang. of Investor Relations Department
  • Ms. Miho Mizuguchi, Exec. Officer, Chief Legal Officer and GM of Legal & Compliance Department
  • Atsuo Omagari, Gen. Mang. of Corp. Communication Department
  • Mr. Kyo Nishikawa, Sr. Exec. Officer, Chief HR Officer & Director
  • Mr. Toshiaki Takagi, Sr. Managing Exec. Officer & Director
  • Mr. Kazuaki Kitabatake, Managing Exec. Officer

What is Terumo's stock symbol?

Terumo trades on the OTCMKTS under the ticker symbol "TRUMY."

How do I buy shares of Terumo?

Shares of TRUMY can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Terumo's stock price today?

One share of TRUMY stock can currently be purchased for approximately $39.95.

How big of a company is Terumo?

Terumo has a market capitalization of $30.34 billion and generates $5.79 billion in revenue each year. The company earns $783.93 million in net income (profit) each year or $1.04 on an earnings per share basis. Terumo employs 26,438 workers across the globe.

What is Terumo's official website?

The official website for Terumo is www.terumo.co.jp.

How can I contact Terumo?

Terumo's mailing address is 2-44-1 Hatagaya Shibuya-ku, Tokyo M0, 151-0072. The company can be reached via phone at 813-3374-8111 or via email at [email protected]

This page was last updated on 11/30/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.